Introduction
Obesity and its metabolic complications, hyperinsulinaemia, insulin resistance, type II diabetes and disorders of plasma lipid transport, are important risk factors for premature cardiovascular disease. While obesity is commonly associated with disorders of plasma lipid transport, not all obese subjects develop this complication. Numerous genes may cause or contribute to the multifactorial obese phenotype in humans, 1 and the obesity-associated disturbances of lipid transport may depend on speci®c obesity genes themselves andaor speci®c mutations in these genes. In addition, interactions of obesity causing mutations with the genetic background of an individual may further modify the expression of genes that control lipid transport.
The apolipoproteins (apo) A-IV, A-I, and C-III are of critical importance for the regulation of plasma lipid transport (reviewed in Ref. 2) . The genes coding for apoA-IV, apoC-III, and apoA-I are arranged in a gene complex 3 located on human chromosome 11. In humans allelic variation in this complex has been associated with hyperlipoproteinaemia, 4 with hypertriglyceridaemia in obesity, 5 with the response of plasma lipid levels to diet, 6 and with atherosclerotic disease. 7 ApoA-IV is a component of triglyceride-rich lipoproteins, of HDL, and of the lipoprotein free plasma fraction. Both apoA-IV and apoA-I, the main protein constituent of HDL, participate in reverse cholesterol transport and confer protection against atherosclerosis.
8±11 ApoC-III, a component of triglyceride-rich lipoproteins and HDL, retards the catabolism of triglyceride-rich particles, and plays a role in the pathogenesis of some forms of hypertriglyceridaemia. 12 In humans, obesity is associated with high apoC-III, but low plasma apoA-I concentrations in plasma. 13, 14 Homozygosity for the missense mutation`fatty' ( fa), Glu269Pro, in the leptin receptor gene causes the obese phenotype in ( faafa) Zucker fatty rats. 15, 16 These rats also display insulin resistance and hypertriglyceridaemia, and are therefore a widely used model for human obesity. Apolipoprotein biosynthesis in livers of Zucker fatty rats is altered. 17±20 In an earlier study we showed that the basal hepatic expression of the apoA-IV gene was several fold higher in Zucker fatty rats than in lean littermates due to a posttranscriptional mechanism, while apoA-I gene expression and apoC-III mRNA abundance were similar in lean and obese animals. 21 Moreover, the transcriptional repression of the apoA-IV gene by a ®sh oil diet that occurred in Zucker lean rats was abolished in Zucker fatty rats. The`fatty' allele was transferred from the Zucker rat strain to the background of the Wistar Kyoto strain by backcross breeding to generate a novel strain of genetically obese rats, referred to as ( faafa) Wistar fatty rats. 22 This permits the analysis of the effects resulting from the obesity mutation`fatty' in two distinct background genomes.
The aim of the present study was to determine whether the genetic background modi®es the effects of a speci®c obesity mutation on the expression of the apolipoprotein genes. For this purpose we compared apoA-IV, A-I, and C-III mRNA abundance and synthesis in livers of Wistar fatty and Zucker fatty rats.
Methods

Materials
Radioactive isotopes were purchased from New England Nuclear (Wilmington, DE), restriction enzymes and RNase free DNase I from Boehringer Mannheim. The Gene Amp 1 XL PCR Kit was purchased from Perkin Elmer (Branchburg, NJ).
Animals
Male Zucker fatty and lean rats and Sprague±Dawley rats aged 10±12 weeks were purchased from Harlan CPB (Harlan Nederland B.V.). Male Wistar fatty and lean rats of the Vc:WDFaTa-fa subline aged 10 weeks were obtained from Vassar College, Animal Resourcesa Biology Department, Poughkeepsie, NY. In contrast to Wistar fatty rats of the diabetic WDFaTa-fa line originally reported by Ikeda et al 22 Wistar fatty rats of the Vc:subline are not diabetic unless fed a high sucrose diet. Mean plasma glucose levels were: Wistar fatty 205AE 25, n 18: Zucker fatty 187AE 12, n 6; Wistar lean 185AE 8, n 18; Zucker lean 158AE 15, n 6; Sprague±Dawley 174AE 30, n 5 (mgadl, mean AE s.d.). The mean body weights did not differ between Zucker fatty and Wistar fatty rats (372 AE 31, n 18 vs 389AE 6 g, n 6) and between Wistar lean and Zucker lean animals (265AE 21, n 18 vs 278 AE 12 g, n 6, mean AE s.d.) The mean body weight of the Sprague±Dawley rats was 311AE 7 g (n 5). The rats were housed in a room with a 12 h light cycle (7±19 h) and were fed regular rat chow or ®sh oil diet and tap water ad libitum for 3 weeks. Rat chow (Laboratory Rodent Diet: Purina Mill Inc., Richmond, IN) contained 26% (wtawt) protein, 54% carbohydrate, 6% ®ber, 6% corn oil, 7% minerals and trace elements, and vitamins. The major fatty acids contained in this diet were: C16:0 palmitic, 11.2%; C18:0 stearic, 2.1%; C18:1 oleic, 25%; C18:2 linoleic, 59.9%. The ®sh oil diet (High Menhaden Oil Diet ICN, Cleveland, OH) contained 20% (wtawt) menhaden oil, 1% corn oil, 20% casein, 33% sucrose, 5% alphacel, 15% cornstarch, 4% mineral mixture, 0.3% DL-methionine, 0.12% a-tocopherol (250 IUag) and 1.2% vitamin mixture. The main fatty acids contained in the ®sh oil diet were: C14:0 myristic, 8.4%; C16:0 palmitic, 15.2%; C16:1 palmitoleic, 11.6%; C18:1 oleic, 9.5%; C18:2 linoleic, 1.81%; C18:3 linoleic, 1.82%; C20:4 arachidonic, 2.3%; C20:5 eicosapentaenoic, 16.0%; and docosahexaenoic C22:6, 10.8%. To avoid autooxidation of o-3 polyunsaturated fatty acids (PUFA), ®sh oil diets were stored in aliquots under nitrogen at À20 C. Rats received fresh aliquots every day. Wistar fatty rats fed ®sh oil diet gained signi®cantly more weight than Wistar fatty rats fed chow (124 AE 63 vs 69AE 31 g. P`0.05), whereas the weight gains of Wistar lean rats fed these diets did not differ (33AE 17 vs 46 AE 18 g). On the day of the experiment food was removed at 8 a.m.; 4±6 h later the rats were anesthetized with sodium pentobarbital (5 mga100 g i.p.). After midline incision the liver was perfused in situ through the portal vein with 5 ml of ice-cold, sterile 10 mM Tris HCl, 5 mM dithiothreitol, 0.3 M sucrose, 5 mMgCl 2 , 0.1% Triton X 405, pH 7.5 and removed for the preparation of total RNA and nuclei. The animal experiments were performed in accordance with the`Principles of Laboratory Animal Care' (NIH publication No. 52-23 revised 1985) and with the Austrian Law on the Protection of Animals, and were approved by the Review Board of the University of Vienna.
Isolation and analysis of total liver RNA Total RNA was extracted from 1 g of liver by the guanidine hydrochloride method. 23 For Northern blotting total liver RNA was denatured with 1 M glyoxal, 50% dimethy1 sulfoxide, and separated by electrophoresis in 1.2% agarose as in earlier experiments. 24 The RNA was transferred to nylon membranes (Zeta Probe 1 , Biorad) by diffusion blotting and hybridized to 32 P labeled cDNA inserts. For quantitation of apolipoprotein mRNA abundance, serial dilutions of total RNA (1, 2 and 4 mg) were applied to nylon membranes by slot blotting (Zeta Probe 1 , Biorad). Full length cDNA inserts coding for apoA-IV, 24 apoA-I (kindly provided by Dr L. Chan), apoC-III 24 and mouse b 2 -microglobulin 25 were cut from recombinant pGEM-3Z vectors with Eco RI, separated by agarose gel electrophoresis, and labeled with (a- cpmamg cDNA using the random primer method. The membranes were hybridized as previously described. 24 Autoradiographs were scanned using a Apolipoprotein gene expression in obese rats E Schuller et al Hirschmann Elscript 400 densitometer. Relative abundance of the apolipoprotein RNAs was calculated from the slopes of the densitometric curves and standardized to the b 2 -microglobulin mRNA content.
Nuclear RNA and run-on transcription assays Nuclear apoA-IV, A-I and C-III RNA abundance was studied in addition to total cellular apolipoprotein mRNA, because we had observed post-transcriptional regulation of apoA-IV and A-I gene expression at the level of nuclear RNA processing in earlier experiments. 21, 26 Liver cell nuclei were isolated by sucrose density gradient centrifugation according to Northemann. 27 The puri®ed nuclei were stored in aliquots at À70 C. Nuclear RNA was extracted with guanidine isothyocyanate and puri®ed by cesium chloride density gradient ultracentrifugation as described previously. 26 Nuclear RNA was analyzed by Northern blotting and quantitative slot blotting as described for total RNA. Cell free transcription was carried out by the method of Birch and Schreiber 28 as described earlier 21 ,24,26,29 using 4 Â 10 7 nucleiareaction. Experimental conditions ensured DNA dependent transcription, and RNA polymerase II activity amounted to 55% of total transcription. The newly synthesized 32 P labeled apoA-IV (7 Â 10 6 cpm) and apoA-I gene transcripts (9 Â 10 6 cpm) were quantitated by dot blot hybridization to excess (5 mg) apoA-IV and apoA-I cDNA immobilized on nitrocellulose membranes (Schleicher & Schuell). Nonspeci®c background hybridization was determined using immobilized nonrecombinant pGEM. Radioactivity was eluted from the ®lters using 0.3 M NaOH and the samples were counted in a liquid scintillation counter for 20 min. A ( 3 H) cRNA standard (1000 cpm) for apoA-l and apoA-IV was included in the hybridization reaction to determine its ef®ciency. No signi®cant differences in hybridization ef®ciency between the experimental groups were found.
Detection of the Glu269Pro leptin receptor mutation
For detection of the Glu269Pro substitution in the leptin receptor gene, genomic DNA was extracted from liver cell nuclei by standard methods. A 1.8 kb segment of the gene was ampli®ed by hot start PCR in a 50 ml reaction containing 20 pm of each primer, 0.2 mm of each dNTP, 1.5 mM Mg acetate and 2 U of Taq polymerase in 1X buffer of the Gene Amp 1 XL PCR Kit (Perkin Elmer) using the primers described by Phillips et al. 16 DNA (0.5 mg) was processed through an initial denaturation of 5 min at 95 C followed by 30 cycles of denaturation at 94 C for 1 min, annealing at 55 C for 1 min, extention at 72 C for 1 min and a ®nal extention at 72 C for 10 min. The A880C substitution resulting in the Glu269Pro mutation was detected by MspI digestion. The digestion products were separated on 1% agarose gels.
Statistics
Differences between mean values were analyzed by analysis of variance and Newman Keul tests. Statistical signi®cance was de®ned as P`0.05. Results are presented as mean AE s.d.
Results
Wistar fatty rats carry the Glu269Pro leptin receptor mutation
The presence of the Glu269Pro leptin receptor mutation in Wistar fatty rats was determined by PCR ampli®ca-tion and restriction digestion ( Figure 1 ). All four Wistar fatty rats that were genotyped exhibited a restriction pattern indistinguishable from that in ( faafa) Zucker fatty rats and were therefore homozygous for Glu269Pro. One out of ®ve Wistar lean rats was heterozygous for Glu269Pro, while the remaining four animals exhibited the restriction pattern of Sprague±Dawley rats, thus carrying two wild-type alleles at this locus.
Basal hepatic apoA-IV, apoA-I, and apoC-III gene expression in Wistar lean, Zucker lean, and Sprague±Dawley rats
To determine the effect of the genetic background of the Wistar and Zucker strain on hepatic apolipoprotein gene expression we ®rst measured total and nuclear apoA-IV, A-I and C-III RNA in lean animals of both strains and, as a reference group, in Sprague±Dawley rats (Table 1) . We found that the genetic background markedly in¯uenced the expression of the apoA-IV and apoA-I genes, but not the apoC-III gene. Basal apoA-IV total RNA in liver of both, Wistar lean and Zucker lean rats was considerable lower than in Sprague±Dawley rats as determined by quantitative slot blotting (Table 1 ) and con®rmed by Northern blotting (not shown). Similar results were obtained for apoA-IV nuclear RNA. ApoA-I total RNA in the liver of Wistar lean rats was roughly two times higher than Figure 1 Wistar fatty rats carry the Glu269Pro leptin receptor mutation. A 1.8 kb segment of the leptin receptor gene was ampli®ed from genomic DNA by PCR using the primer sequences described by Phillips et al 16 and digested with MspI to detect the Glu269Pro mutation. The digestion products were separated on 1% agarose gels. MspI digestion showed a single restriction site in Sprague±Dawley rats (lane 2) and in homozygous lean Wistar rats (lane 6) In homozygous (faafa) Wistar fatty and (faafa) Zucker fatty rats, MspI digestion resulted in a second cleavage of the larger fragment. The resulting additional 130 bp fragment is not shown (Wistar fatty, lanes 7 and 8; Zucker fatty, lane 9). Lane 3, heterozygous Wistar lean rat; lanes 4 and 5, heterozygous Zucker lean rats. Lane 1, molecular weight standard (bottom to top 600, 700, 800, 900, 1000, 1100, 1200, 1300, !1400 bp).
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E Schuller et al in Zucker lean and Sprague±Dawley rats ( Table 1 ). These differences were con®rmed by quantitative slot blotting of apoA-I nuclear RNA (Table 1) . Hepatic apoC-III total and nuclear RNA levels did not differ signi®cantly among the three strains ( Table 1) .
Effect of obesity due to the Glu269Pro leptin receptor mutation on basal hepatic apoA-IV, apoA-I and apoC-III gene expression in Wistar and Zucker fatty rats
To ask whether the genetic background in¯uences the effect of the Glu269Pro leptin receptor mutation on apolipoprotein gene expression, we compared basal hepatic apoA-IV, A-I and C-III expression in Wistar fatty rats and Zucker fatty rats to the expression levels in lean littermates. We found that the genetic background signi®cantly in¯uenced the effects of Glu269Pro on the apoA-I and C-III genes, but not the effect on the apoA-IV gene. ApoA-IV mRNA abundance was increased 2±4-fold by a post-transcriptional mechanism operating in the nucleus in livers of both Wistar fatty and Zucker fatty rats vs lean controls. ApoA-IV total and nuclear RNA levels were consistently increased in two independent sets of Wistar fatty rats as determined by quantitative slot blotting (Table 1 and 2, Figure 3 ) and con®rmed by Northern blot analysis of total cellular RNA (Figure 2 , top panel) and nuclear RNA (not shown). ApoA-IV gene transcription rates, however, did not differ between Wistar fatty and Wistar lean rats (Table 2, Figure 3 ). In livers of Zucker fatty rats apoA-IV gene expression was 2±3-fold higher than in Zucker lean rats. Both apoA-IV total and nuclear RNA levels were increased to a similar extent (Table 1) , con®rming our earlier results. 21 In these earlier experiments apoA-IV gene transcription rates did not differ between Zucker fatty and Zucker ApoA-IV gene transcription rates were determined in run-on assays using isolated liver cell nuclei from rats fed ®sh oil diet or rat chow for 3 weeks (three pools of two rats/group). Hybridizations of newly synthesized 32 P nuclear RNA were performed in duplicate. Total hepatic and nuclear apoA-IV RNA abundance were determined in duplicate by quantitative slot blotting in individual samples from ®ve to six rats/group. Relative abundance of apolipoprotein mRNA was standardized to b 2 -microglobulin mRNA. Results are expressed as percentage of Wistar lean control and given as mean AE s.d. a Signi®cantly different from Wistar lean on rat chow, P`0.01. Apolipoprotein gene expression in obese rats E Schuller et al lean rats, implicating post-transcriptional events as the causative mechanism of enhanced apoA-IV gene expression. 21 ApoA-I gene expression in livers of Wistar fatty rats was reduced transcriptionally to about half of that in Wistar lean rats (Tables 1 and 3, Figure 2 middle panel, Figure 4 ). ApoA-I gene transcription rates were decreased to a similar extent as apoA-I total and nuclear RNA levels. By contrast, hepatic apoA-I total mRNA and nuclear RNA abundance did not differ between fatty and lean rats of the Zucker strain (Table 1) , con®rming our previous results. 21 ApoC-III total RNA abundance in livers of Wistar fatty rats was about 2-fold higher than in Wistar lean rats, whereas apoC-III nuclear RNA did not differ signi®cantly between Wistar fatty and Wistar lean rats as determined by quantitative slot blotting (Table 1, Figure 2 lower panel). These ®ndings were con®rmed in two additional experiments using independent sets of rats: apoC-III total RNA was signi®cantly increased to 174AE 15 (P`0.05) and 224AE 28 (P`0.01) vs 100 AE 25, and 100AE 9% (analysis of variance, Newman±Keul tests, ®ve to six ratsagroup). ApoC-III nuclear RNA did not differ signi®cantly between Wistar fatty and Wistar lean rats (134AE 11 and 97 AE 30 vs 100 AE 20 and 100 AE 30% in lean controls). These results suggest upregulation at the level of mRNA stability in the cytoplasm in livers of Wistar fatty rats. In livers of Zucker rats neither apoC-III total nor nuclear RNA differed between fatty and lean animals (Table 1) , as reported earlier. 21 Since apoC-III protein production is increased in perfusates from livers of Zucker fatty rats, 17 upregulation of apoC-III gene expression in Zucker fatty rats probably occurs at the translational or post-translational level as described for the effect of dietary sucrose on hepatic apoC-III gene expression. 24 Regulation of hepatic apoA-IV, apoA-I and apoC-III gene expression by a ®sh oil diet in Wistar lean and Wistar rats
To determine whether the genetic background of the Wistar and Zucker strain in¯uences diet-induced apolipoprotein gene regulation, we studied the effect of a ®sh oil diet on hepatic apolipoprotein mRNA synthesis and abundance in Wistar lean rats. The ®sh oil diet transcriptionally reduced apoA-IV gene expression about 5-fold ( Table 2 , Figures 2 and 3 ) and apoA-I gene expression about 2-fold compared to rat chow (Table 3 , Figures 2 and 4) . This reduction of apoA-IV and apoA-I transcription in Wistar lean rats closely resembled the transcriptional down-regulation of these two genes by the same commercial High Menhaden Oil diet in livers of several sets of Zucker lean rats studied in our previous experiments. 21 To determine whether the interactions between the fatty mutation and the genetic background of the Wistar and Zucker strain were modi®ed by diet, we studied the effect of dietary ®sh oil on hepatic apolipoprotein gene expression in Wistar fatty rats. We found that the effect of dietary ®sh oil on apoA-IV and apoA-I gene expression in Wistar fatty rats was markedly distinct from that observed earlier in Zucker fatty rats. 21 In Wistar fatty ApoA-I gene transcription rates were determined in run-on assays using isolated liver cell nuclei from rats fed ®sh oil diet or rat chow for 3 weeks (three pools of two rats/group). Hybridizations of newly synthesized 32 P nuclear RNA were performed in duplicate. Total hepatic and nuclear apoA-I RNA abundance were determined in duplicate by quantitative slot blotting in individual samples from ®ve to six rats/group. Relative abundance of apolipoprotein mRNA was standardized to b 2 -microglobulin mRNA. Results are expressed as percentage of Wistar lean control and given as mean AE s.d. Apolipoprotein gene expression in obese rats E Schuller et al rats the ®sh oil diet reduced apoA-IV gene transcription to about half the level observed in Wistar fatty rats fed chow (Table 2, Figure 3 ). This reduction was paralleled by a decrease in nuclear apoA-IV RNA as determined by quantitative slot blotting (Figure 3 ). Northern blots of nuclear RNA showed a comparable reduction in the intensity of all nuclear apoA-IV mRNA precursor bands (not shown). Despite the reduction of the apoA-IV gene transcription rate and nuclear apoA-IV RNA abundance in Wistar fatty rats on a ®sh oil diet, hepatic apoA-IV total RNA did not decrease ( Table 2 , Figures 2  and 3) . Hence, the transcriptional response was blunted by post-transcriptional effects as observed earlier in the regulation of apoA-IV and C-III by thyroid hormones. 29 The reduction of the apoA-IV transcription rate by dietary ®sh oil in Wistar fatty rats clearly differs from the absence of a transcriptional response that was observed in several sets of Zucker fatty rats under the same experimental conditions. 21 Dietary ®sh oil had no signi®cant effect on apoA-I gene transcription, nuclear or total apoA-I mRNA abundance in Wistar fatty rats (Table 3 , Figures 2  and 4 ). This lack of a transcriptional response to ®sh oil diet in Wistar fatty rats differs from the reduction of apoA-I transcription in Zucker fatty rats, which was quantitatively similar to the reduction in lean animals of both strains in our earlier experiments. 21 Dietary regulation of hepatic apoA-IV and apoA-I gene expression in Wistar and Zucker rats with the same obesity-causing mutation is therefore strongly modi®ed by the genetic background.
Neither in Wistar lean nor in Wistar fatty rats were hepatic apoC-III total and nuclear RNA levels signi®cantly altered by the ®sh oil diet (total RNA : Wistar lean 100AE 12%, Wistar lean ®sh oil 87AE 20%, Wistar fatty 100 AE 28%, Wistar fatty ®sh oil 83 AE 13%; nuclear RNA-Wistar lean 100AE 30%, Wistar lean ®sh oil 77 AE 27%, Wistar fatty 100AE 31%, Wistar fatty ®sh oil 74 AE 26%, quantitative slot blotting, con®rmed by Northern blotting, Figure 2 lower panel) . Similarly, we found no changes in apoC-III nuclear or mRNA abundance in lean and fatty Zucker rats under identical dietary conditions. 21 
Discussion
Our studies in lean and fatty rats of the Zucker and Wistar strains clearly show that the effect of the obesity mutation`fatty' on hepatic expression of apoA-IV, A-I, and C-III is in¯uenced by the strainspeci®c background genome.
Strain-speci®c differences in hepatic apolipoprotein gene expression were already apparent in lean animals, as the basal apoA-I and apoA-IV mRNA and nuclear RNA levels differed among the Zucker, Wistar and Sprague±Dawley strains. Interestingly, an inverse relationship between apoA-I and apoA-IV mRNA abundance was observed among the three strains studied. Wistar lean rats exhibited the highest apoA-I and the lowest apoA-IV mRNA abundance, whereas Sprague-Dawley rats displayed the lowest apoA-I mRNA and the highest apoA-IV mRNA expression levels, and Zucker lean rats showed intermediate values for both apoA-I and apoA-IV mRNA abundance. The apoA-I and apoA-IV genes share functionally important sequences located in the apoC-III promoter and in the central intergenic region apoA-IVaC-III, which enhance the transcription of both genes in liver cells. 30 Competition for binding of distinct trans acting factors to these common enhancer elements may contribute to the inverse relationship of apoA-I and A-IV expression among rat strains. Strain-speci®c differences of hepatic apoA-IV gene expression in inbred mice have been attributed to trans acting factors. 31 In addition, part of the expressional difference in hepatic apoA-IV mRNA among these strains has been ascribed to cis elements. speci®cally, insertions or deletions of a stretch of 12 nucleotides in a conserved tandem repeat region at the 3 H end of the apoA-IV gene have been linked to differences in apoA-IV mRNA abundance in these mice. 31, 32 It is conceivable that similar structural variations also contributed to the differential basal apoA-IV gene expression in the rat strains studied here.
In obese rats the strain speci®c genetic background in¯uenced the effect of the mutation`fatty' on hepatic apolipoprotein gene expression: in Wistar fatty rats apoA-I gene expression was lower than in Wistar lean rats, whereas in Zucker rats it did not differ between fatty and lean animals. Moreover, basal hepatic apoC-III total RNA was increased in Wistar fatty, but not in Zucker fatty rats as compared to lean rats. Several other examples for major effects of the genetic background on metabolic sequelae of obesity mutations have been reported. Atherosclerosis susceptibility varies in a strain-speci®c pattern in genetically obese inbred mice. 33 The severity of diabetes in dbadb mice and ( faafa) fatty rats depends on the genetic background. 34, 35 In ( faafa) Zucker fatty rats pancreatic insulin secretion and proinsulin gene expression increases with the development of obesity, resulting in moderate hyperglycemia. 35, 36 In WDFaTa ( faafa) Wistar fatty rats, proinsulin gene expression is not commensurate with the increases in fat deposits and overt diabetes develops. 35 Our ®nding that basal apoA-IV gene expression was increased by a nuclear post-transcriptional mechanism in both male Wistar and Zucker fatty rats is consistent with a direct effect of obesity on apoA-IV gene expression. Recently, an increased hepatic apoA-IV mRNA abundance level has been shown in female Sprague±Dawley rats made obese by ventromedial hypothalamic lesions. 37 Hence, hepatic apoA-IV gene expression is also enhanced in nongenetic obesity, and defective leptin signaling itself is unlikely to account for apoA-IV overexpression in ( faafa) Wistar and Zucker rats. In our study, an increased apoA-IV mRNA abundance level was mainApolipoprotein gene expression in obese rats E Schuller et al tained when fatty rats were fed a ®sh oil diet, even though this diet markedly reduced apoA-IV expression in lean animals. Moreover, ApoA-IV mRNA expression remained elevated in Wistar fatty rats fed ®sh oil, albeit apoA-IV gene transcription was repressed and nuclear apoA-IV RNA abundance was decreased. The transcriptional response to the ®sh oil diet was blunted by post-transcriptional events. Such a mechanism has also been observed in the regulation of apoA-IV and apoC-III gene expression by thyroid hormones. 29 Thus, enhanced hepatic apoA-IV gene expression may be a functionally important response to obesity. The physiological relevance of this response may relate to apoA-IV's role in reverse cholesterol transport and triglyceride metabolism andaor to its putative function as a satiety factor that was suggested by some, but not all studies. 38, 39 The interactions of the fatty mutation with the two genetic backgrounds were modi®ed by diet: the ®sh oil diet reduced apoA-I gene expression transcriptionally in Zucker fatty rats, but not in Wistar fatty rats. Conversely, this diet reduced apoA-IV gene transcription and nuclear RNA abundance in Wistar fatty rats, but not in Zucker fatty rats. These observations are consistent with a coordinated regulation of apoA-I and apoA-IV gene transcription, since the reciprocal pattern of basal expression was accentuated by a dietary perturbation. The molecular mechanisms that mediate the response of apolipoprotein gene transcription to o-3 polyunsaturated fatty acids (PUFA) contained in ®sh oil diet are incompletely understood. PUFA reduce the transcription of several genes coding for lipogenic and glycolytic enzymes, such as malic enzymes, fatty acid synthase, the spot 14 protein, and L-pyruvate kinase in rat liver. 40 Like the downregulation of these enzymes, the repression of apoA-I transcription by dietary ®sh oil appears to be a direct substrate effect, since it can be evoked in vitro by incubation of primary rat hepatocyte cultures with eicosapentaenoic and docosahexaenoic acid. 41 The presence of one fa allele in faaFa heterozygous lean rats vs lean FaaFa homozygous lean animals has been reported to result in an intermediate expression of several traits like body fat, fat cell size, lipoprotein lipase expression, or plasma leptin concentration relative to the two homozygous genotypes. 42, 43 By contrast, other variables like malic enzyme or fatty acid synthase activity, serum triglycerides, cholesterol and glucose did not differ between faaFa and FaaFa animals. 43 The present study did not attempt to distinguish hepatic apolipoprotein gene expression in lean faaFa from that in lean FaaFa animals. If present, an intermediate phenotype in fa heterozygotes may have reduced some of the differences in apolipoprotein gene expression between fatty ( faafa) rats and lean (Faa±) controls reported here.
In conclusion, our studies in rats show that the effects of a speci®c obesity-mutation on hepatic apolipoprotein gene regulation are modi®ed substantially by the strain-speci®c genetic background. By analogy these results suggest that lipid transport disturbances resulting from a speci®c obesity-mutation in humans may differ between obese individuals according to their genetic background.
